Pharmaceutical Manufacturing Market Size to touch USD 1,599.9 Billion by 2030

Pharmaceutical Manufacturing Market Size to touch USD 1,599.9 Billion by 2030

Acumen Research and Consulting has announced the addition of the “Pharmaceutical Manufacturing Market” report to their offering.

The Pharmaceutical Manufacturing Market Industry Report 2030 is an in depth study analyzing the current state of the Pharmaceutical Manufacturing Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Pharmaceutical Manufacturing Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Pharmaceutical Manufacturing Market also discusses the opportunity areas for investors.

Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2432

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Pharmaceutical Manufacturing MarketMarket Players as below:

Some of the top pharmaceutical manufacturing companies offered in the professional report include AstraZeneca, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Lonza, Merck & Co. Inc., Novartis AG, Pfizer, Inc., and Sanofi SA.

Market Segmentation:

Pharmaceutical Manufacturing Market By Formulation

  • Tablets
  • Capsules
  • Injectable
  • Sprays Suspensions
  • Powders
  • Other Formulations

Pharmaceutical Manufacturing Market By Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Inhalations
  • Others

Pharmaceutical Manufacturing Market By Prescription

  • Prescription Medicines
  • Over-the-counter (OTC) Medicines

Pharmaceutical Manufacturing Market By Drug Development

  • Outsource
  • In-house

Pharmaceutical Manufacturing Market By Distribution Channel

  • Online
  • Offline

Table Of Contents:

CHAPTER 1. Industry Overview of Pharmaceutical Manufacturing Market

1.1. Definition and Scope

1.1.1. Definition of Pharmaceutical Manufacturing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Pharmaceutical Manufacturing Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Pharmaceutical Manufacturing Market By Formulation

1.2.3. Pharmaceutical Manufacturing Market By Route of Administration

1.2.4. Pharmaceutical Manufacturing Market By Prescription

1.2.5. Pharmaceutical Manufacturing Market By Drug Development

1.2.6. Pharmaceutical Manufacturing Market By Distribution Channel

1.2.7. Pharmaceutical Manufacturing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Manufacturing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Pharmaceutical Manufacturing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Pharmaceutical Manufacturing Market By Formulation

5.1. Introduction

5.2. Pharmaceutical Manufacturing Revenue By Formulation

5.2.1. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast, By Formulation, 2018-2030

5.2.2. Tablets

5.2.2.1. Tablets Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Capsules

5.2.3.1. Capsules Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Injectable

5.2.4.1. Injectable Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Sprays

5.2.5.1. Sprays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Suspensions

5.2.6.1. Suspensions Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Powders

5.2.7.1. Powders Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.8. Others

5.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Pharmaceutical Manufacturing Market By Route of Administration

6.1. Introduction

6.2. Pharmaceutical Manufacturing Revenue By Route of Administration

6.2.1. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030

6.2.2. Topical

6.2.2.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Parenteral

6.2.3.1. Parenteral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Oral

6.2.4.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.5. Inhalations

6.2.5.1. Inhalations Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.6. Others

6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Pharmaceutical Manufacturing Market By Prescription

7.1. Introduction

7.2. Pharmaceutical Manufacturing Revenue By Prescription

7.2.1. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast, By Prescription, 2018-2030

7.2.2. Prescription Medicines

7.2.2.1. Prescription Medicines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Over-the-counter (OTC) Medicines

7.2.3.1. Over-the-counter (OTC) Medicines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. Pharmaceutical Manufacturing Market By Drug Development

8.1. Introduction

8.2. Pharmaceutical Manufacturing Revenue By Drug Development

8.2.1. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast, By Drug Development, 2018-2030

8.2.2. Outsource

8.2.2.1. Outsource Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.3. In-house

8.2.3.1. In-house Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 9. Pharmaceutical Manufacturing Market By Distribution Channel

9.1. Introduction

9.2. Pharmaceutical Manufacturing Revenue By Distribution Channel

9.2.1. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030

9.2.2. Online

9.2.2.1. Online Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

9.2.3. Offline

9.2.3.1. Offline Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 10. North America Pharmaceutical Manufacturing Market By Country 

10.1. North America Pharmaceutical Manufacturing Market Overview

10.2. U.S.

10.2.1. U.S. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.2.2. U.S. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.2.3. U.S. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.2.4. U.S. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

10.2.5. U.S. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.3. Canada

10.3.1. Canada Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.3.2. Canada Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.3.3. Canada Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.3.4. Canada Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

10.3.5. Canada Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.4. North America PEST Analysis

CHAPTER 11. Europe Pharmaceutical Manufacturing Market By Country

11.1. Europe Pharmaceutical Manufacturing Market Overview

11.2. U.K.

11.2.1. U.K. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.2.2. U.K. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.2.3. U.K. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.2.4. U.K. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

11.2.5. U.K. Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.3. Germany

11.3.1. Germany Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.3.2. Germany Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.3.3. Germany Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.3.4. Germany Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

11.3.5. Germany Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.4. France

11.4.1. France Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.4.2. France Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.4.3. France Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.4.4. France Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

11.4.5. France Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.5. Spain

11.5.1. Spain Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.5.2. Spain Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.5.3. Spain Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.5.4. Spain Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

11.5.5. Spain Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.6. Rest of Europe

11.6.1. Rest of Europe Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.6.2. Rest of Europe Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.6.3. Rest of Europe Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.6.4. Rest of Europe Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

11.6.5. Rest of Europe Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.7. Europe PEST Analysis

CHAPTER 12. Asia Pacific Pharmaceutical Manufacturing Market By Country

12.1. Asia Pacific Pharmaceutical Manufacturing Market Overview

12.2. China

12.2.1. China Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.2.2. China Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.2.3. China Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.2.4. China Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.2.5. China Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.3. Japan

12.3.1. Japan Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.3.2. Japan Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.3.3. Japan Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.3.4. Japan Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.3.5. Japan Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.4. India

12.4.1. India Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.4.2. India Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.4.3. India Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.4.4. India Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.4.5. India Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.5. Australia

12.5.1. Australia Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.5.2. Australia Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.5.3. Australia Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.5.4. Australia Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.5.5. Australia Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.6. South Korea

12.6.1. South Korea Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.6.2. South Korea Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.6.3. South Korea Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.6.4. South Korea Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.6.5. South Korea Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.7. Rest of Asia-Pacific

12.7.1. Rest of Asia-Pacific Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.7.2. Rest of Asia-Pacific Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.7.3. Rest of Asia-Pacific Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.7.4. Rest of Asia-Pacific Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

12.7.5. Rest of Asia-Pacific Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.8. Asia Pacific PEST Analysis

CHAPTER 13. Latin America Pharmaceutical Manufacturing Market By Country

13.1. Latin America Pharmaceutical Manufacturing Market Overview

13.2. Brazil

13.2.1. Brazil Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.2.2. Brazil Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.2.3. Brazil Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.2.4. Brazil Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

13.2.5. Brazil Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.3. Mexico

13.3.1. Mexico Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.3.2. Mexico Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.3.3. Mexico Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.3.4. Mexico Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

13.3.5. Mexico Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.4. Rest of Latin America

13.4.1. Rest of Latin America Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.4.2. Rest of Latin America Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.4.3. Rest of Latin America Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.4.4. Rest of Latin America Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

13.4.5. Rest of Latin America Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.5. Latin America PEST Analysis

CHAPTER 14. Middle East & Africa Pharmaceutical Manufacturing Market By Country 

14.1. Middle East & Africa Pharmaceutical Manufacturing Market Overview

14.2. GCC

14.2.1. GCC Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

14.2.2. GCC Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.2.3. GCC Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

14.2.4. GCC Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

14.2.5. GCC Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.3. South Africa

14.3.1. South Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

14.3.2. South Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.3.3. South Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

14.3.4. South Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

14.3.5. South Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.4. Rest of Middle East & Africa

14.4.1. Rest of Middle East & Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Formulation, 2018-2030

14.4.2. Rest of Middle East & Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.4.3. Rest of Middle East & Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

14.4.4. Rest of Middle East & Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Drug Development, 2018-2030

14.4.5. Rest of Middle East & Africa Pharmaceutical Manufacturing Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.5. Middle East & Africa PEST Analysis

CHAPTER 15. Player Analysis Of Pharmaceutical Manufacturing Market

15.1. Pharmaceutical Manufacturing Market Company Share Analysis

15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

15.2.2. New Product Launches and Product Enhancements

15.2.3. Mergers And Acquisition In Global Pharmaceutical Manufacturing Market

15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 16. Company Profile

16.1. AstraZeneca

16.1.1. Company Snapshot

16.1.2. Business Overview

16.1.3. Financial Overview

16.1.3.1. Revenue (USD Billion), 2021

16.1.3.2. AstraZeneca 2021 Pharmaceutical Manufacturing Business Regional Distribution

16.1.4. Product /Service and Specification

16.1.5. Recent Developments & Business Strategy

16.2. Eli Lilly and Company

16.3. F. Hoffmann-La Roche Ltd.

16.4. GlaxoSmithKline plc

16.5. Johnson & Johnson

16.6. Lonza

16.7. Merck & Co. Inc.

16.8. Novartis AG

16.9. Pfizer, Inc.

16.10. Sanofi SA

Ask Query Here: Richard@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/2432

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

admin

Leave a Reply

Your email address will not be published. Required fields are marked *